artificial intelligence machine learning deep learning AI ML DL US Food and Drug Administration FDA software clinical decision support tools CDS mobile health software digital health applications medical professionals diagnosis treatment guidelines rules and regulations devices wearables wellbeing risks physician clinician patient strategy draft guidance strategy algorithms prediction innovation press statement smart watch technology science

FDA’s latest clarifications on the use of AI software and clinical decision support tools

The US Food and Drug Administration (FDA) released a new set of guidance documents last Thursday (26 September) to clarify its stand on regulating clinical decision support (CDS) tools including artificial intelligence (AI) driven and mobile health software that assist medical professionals in diagnosing and treating patients.  The new guidelines also beef up four previous final…